{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:06:40Z","timestamp":1789330000313,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16218-5","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:13:54Z","timestamp":1779682434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Surgical extent, tumor size, and calcitonin levels in medullary thyroid carcinoma: impact on oncologic outcomes in a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3895-5817","authenticated-orcid":false,"given":"Ekin Yi\u011fit","family":"K\u00f6ro\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1848-888X","authenticated-orcid":false,"given":"Berna","family":"Evranos \u00d6\u011fmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8905-3955","authenticated-orcid":false,"given":"Muzaffer Serdar","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9080-4974","authenticated-orcid":false,"given":"Bar\u0131\u015f","family":"Saylam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9138-4605","authenticated-orcid":false,"given":"Hilal","family":"Ahsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1552-706X","authenticated-orcid":false,"given":"Cevdet","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2501-935X","authenticated-orcid":false,"given":"Oya","family":"Topalo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7437-1176","authenticated-orcid":false,"given":"Reyhan","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7526-8827","authenticated-orcid":false,"given":"Bekir","family":"\u00c7akir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"6","key":"16218_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the American Thyroid Association Guidelines Task Force on medullary thyroid carcinoma. Thyroid. 2015;25(6):567\u2013610. https:\/\/doi.org\/10.1089\/thy.2014.0335.","journal-title":"Thyroid"},{"issue":"12","key":"16218_CR2","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti S, Durante C, Hartl D, Leboulleux S, Locati L, Newbold K, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(12):1856\u201383. https:\/\/doi.org\/10.1093\/annonc\/mdz400.","journal-title":"Ann Oncol"},{"key":"16218_CR3","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Thyroid Carcinoma Plymouth Meeting, PA; 2025."},{"issue":"1","key":"16218_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.surg.2021.04.052","volume":"171","author":"TS Yamashita","year":"2022","unstructured":"Yamashita TS, Rogers RT, Foster TR, Lyden ML, Morris JC, Thompson GB, et al. Medullary thyroid cancer: What is the optimal management of the lateral neck in a node negative patient at index operation? Surgery. 2022;171(1):177\u201381. https:\/\/doi.org\/10.1016\/j.surg.2021.04.052.","journal-title":"Surgery"},{"key":"16218_CR5","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.1245\/s10434-021-09683-8","volume":"28","author":"PM Spanheimer","year":"2021","unstructured":"Spanheimer PM, Ganly I, Chou JF, Capanu M, Nigam A, Ghossein RA, et al. Prophylactic lateral neck dissection for medullary thyroid carcinoma is not associated with improved survival. Ann Surg Oncol. 2021;28:6572\u20139. https:\/\/doi.org\/10.1245\/s10434-021-09683-8.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"16218_CR6","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/oncolo\/oyad232","volume":"28","author":"AJ Papachristos","year":"2023","unstructured":"Papachristos AJ, Nicholls LE, Mechera R, Aniss AM, Robinson B, Clifton-Bligh R, et al. Management of medullary thyroid cancer: patterns of recurrence and outcomes of reoperative surgery. Oncologist. 2023;28(12):1064\u201371. https:\/\/doi.org\/10.1093\/oncolo\/oyad232.","journal-title":"Oncologist"},{"key":"16218_CR7","doi-asserted-by":"publisher","first-page":"1433329","DOI":"10.3389\/fendo.2024.1433329","volume":"15","author":"Z Tao","year":"2024","unstructured":"Tao Z, Deng X, Ding Z, Guo B, Fan Y. Thyroidectomy without lymph node dissection should be considered for stage T1 medullary thyroid carcinoma: a population-based cohort study. Front Endocrinol (Lausanne). 2024;15:1433329. https:\/\/doi.org\/10.3389\/fendo.2024.1433329.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"16218_CR8","doi-asserted-by":"crossref","unstructured":"Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on cancer\/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer: what changed and why? Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA; 2017. pp. 751-6.","DOI":"10.1089\/thy.2017.0102"},{"key":"16218_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12020-015-0849-6","volume":"53","author":"H Kwon","year":"2016","unstructured":"Kwon H, Kim WG, Jeon MJ, Song DE, Lee Y-M, Sung T-Y, et al. Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy. Endocrine. 2016;53:174\u201381. https:\/\/doi.org\/10.1007\/s12020-015-0849-6.","journal-title":"Endocrine"},{"key":"16218_CR10","unstructured":"Rosen J, Lloyd R, Brierley J, Grogan R, Haddad R, Hunt J et al. Thyroid-medullary. AJCC cancer staging Man. 2017:891\u2013901."},{"issue":"7","key":"16218_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.oraloncology.2013.03.443","volume":"49","author":"RM Tuttle","year":"2013","unstructured":"Tuttle RM, Ganly I. Risk stratification in medullary thyroid cancer: moving beyond static anatomic staging. Oral Oncol. 2013;49(7):695\u2013701. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.03.443.","journal-title":"Oral Oncol"},{"issue":"10","key":"16218_CR12","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.3390\/cancers12102894","volume":"12","author":"H Park","year":"2020","unstructured":"Park H, Park J, Choi MS, Kim J, Kim H, Shin JH, et al. Preoperative serum calcitonin and its correlation with extent of lymph node metastasis in medullary thyroid carcinoma. Cancers (Basel). 2020;12(10):2894. https:\/\/doi.org\/10.3390\/cancers12102894.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"16218_CR13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1210\/jcem.85.2.6556","volume":"85","author":"J-M Cohen Rg, Campos","year":"2000","unstructured":"Cohen Rg, Campos J-M, Sala\u00fcn C, Massoud Heshmati H, Kraimps J-L, Proye C, et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. J Clin Endocrinol Metab. 2000;85(2):919\u201322. https:\/\/doi.org\/10.1210\/jcem.85.2.6556.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"16218_CR14","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1210\/jc.2009-2368","volume":"95","author":"A Machens","year":"2010","unstructured":"Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab. 2010;95(6):2655\u201363. https:\/\/doi.org\/10.1210\/jc.2009-2368.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"16218_CR15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s00268-022-06448-6","volume":"46","author":"L Juez","year":"2022","unstructured":"Juez L, Mercader E, Amunategui I, Febrero B, Rodr\u00edguez J, G\u00f3mez-Ram\u00edrez J, et al. Extension of prophylactic surgery in medullary thyroid carcinoma. Differences between sporadic and hereditary tumours according to calcitonin levels and lymph node involvement. World J Surg. 2022;46(4):820\u20138. https:\/\/doi.org\/10.1007\/s00268-022-06448-6.","journal-title":"World J Surg"},{"issue":"3","key":"16218_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000499018","volume":"8","author":"EM Opsahl","year":"2019","unstructured":"Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, et al. The role of calcitonin in predicting the extent of surgery in medullary thyroid carcinoma: a nationwide population-based study in Norway. Eur Thyroid J. 2019;8(3):159\u201366. https:\/\/doi.org\/10.1159\/000499018.","journal-title":"Eur Thyroid J"},{"issue":"8","key":"16218_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/jamaoto.2025.0542","volume":"151","author":"Y Du","year":"2025","unstructured":"Du Y, Shen C, Song K, Liu C, Li Z, Liu Z, et al. Updated thresholds of basal calcitonin level and extent of lymph node metastasis in initially treated medullary thyroid cancer. JAMA Otolaryngol Head Neck Surg. 2025;151(8):761\u20137. https:\/\/doi.org\/10.1001\/jamaoto.2025.0542.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"16218_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1200\/JCO.21.01329","volume":"40","author":"B Xu","year":"2022","unstructured":"Xu B, Fuchs TL, Ahmadi S, Alghamdi M, Alzumaili B, Bani M-A, et al. International medullary thyroid carcinoma grading system: a validated grading system for medullary thyroid carcinoma. J Clin Oncol. 2022;40(1):96\u2013104. https:\/\/doi.org\/10.1200\/JCO.21.01329.","journal-title":"J Clin Oncol"},{"issue":"2","key":"16218_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1089\/thy.2014.0277","volume":"25","author":"SC Lindsey","year":"2015","unstructured":"Lindsey SC, Ganly I, Palmer F, Tuttle RM. Response to initial therapy predicts clinical outcomes in medullary thyroid cancer. Thyroid. 2015;25(2):242\u20139. https:\/\/doi.org\/10.1089\/thy.2014.0277.","journal-title":"Thyroid"},{"issue":"7","key":"16218_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/thy.2024.0076","volume":"34","author":"A Machens","year":"2024","unstructured":"Machens A, Lorenz K, Weber F, Dralle H. Anatomical patterns of nodal spread in unilateral papillary and medullary thyroid cancer. Thyroid. 2024;34(7):871\u20139. https:\/\/doi.org\/10.1089\/thy.2024.0076.","journal-title":"Thyroid"},{"issue":"12","key":"16218_CR21","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/kjm2.12122","volume":"35","author":"SY Bae","year":"2019","unstructured":"Bae SY, Jung SP, Choe JH, Kim JS, Kim JH. Prediction of lateral neck lymph node metastasis according to preoperative calcitonin level and tumor size for medullary thyroid carcinoma. Kaohsiung J Med Sci. 2019;35(12):772\u20137. https:\/\/doi.org\/10.1002\/kjm2.12122.","journal-title":"Kaohsiung J Med Sci"},{"issue":"11","key":"16218_CR22","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1210\/clinem\/dgae279","volume":"109","author":"S Abou Azar","year":"2024","unstructured":"Abou Azar S, Tobias J, Applewhite M, Angelos P, Keutgen XM. Medullary thyroid cancer: single institute experience over 3 decades and risk factors for recurrence. J Clin Endocrinol Metab. 2024;109(11):2729\u201334. https:\/\/doi.org\/10.1210\/clinem\/dgae279.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"16218_CR23","doi-asserted-by":"publisher","first-page":"e2968","DOI":"10.1210\/clinem\/dgab214","volume":"106","author":"A Machens","year":"2021","unstructured":"Machens A, Lorenz K, Weber F, Dralle H. Exceptionality of distant metastasis in node-negative hereditary and sporadic medullary thyroid cancer: lessons learned. J Clin Endocrinol Metab. 2021;106(8):e2968\u201379. https:\/\/doi.org\/10.1210\/clinem\/dgab214.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"16218_CR24","doi-asserted-by":"publisher","first-page":"6466","DOI":"10.3390\/ijms24076466","volume":"24","author":"C Gambardella","year":"2023","unstructured":"Gambardella C, Mongardini FM, Paolicelli M, Bentivoglio D, Cozzolino G, Ruggiero R, et al. Role of Inflammatory Biomarkers (NLR, LMR, PLR) in the Prognostication of Malignancy in Indeterminate Thyroid Nodules. Int J Mol Sci. 2023;24(7):6466. https:\/\/doi.org\/10.3390\/ijms24076466.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"16218_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12902-019-0435-7","volume":"19","author":"C Gambardella","year":"2019","unstructured":"Gambardella C, Offi C, Clarizia G, Romano RM, Cozzolino I, Montella M, et al. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review. BMC Endocr Disord. 2019;19(1):103. https:\/\/doi.org\/10.1186\/s12902-019-0435-7.","journal-title":"BMC Endocr Disord"},{"issue":"Suppl 1","key":"16218_CR26","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/j.ijsu.2014.05.015","volume":"12","author":"G Conzo","year":"2014","unstructured":"Conzo G, Polistena A, Cal\u00f2 PG, Bononi P, Gambardella C, Mauriello C, et al. Efficacy of combined treatment for anaplastic thyroid carcinoma: results of a multinstitutional retrospective analysis. Int J Surg. 2014;12(Suppl 1):S178\u201382. https:\/\/doi.org\/10.1016\/j.ijsu.2014.05.015.","journal-title":"Int J Surg"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16218-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16218-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16218-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:37:47Z","timestamp":1784252267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16218-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16218"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16218-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ankara Bilkent City Hospital ethical committee approval was obtained on 11.06.2025 (TABED-2-25-1300) in accordance with the ethical standards of the Declaration of Helsinki. Informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"866"}}